Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qihuang Yishen Granule for proteinuria in diabetic kidney disease
ChiCTR1900022275Phase 3Not yet recruiting
- Sponsor
- 中国中医科学院望京医院
- Start
- Mar 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Qihuang Yishen Granule in diabetic glomerulosclerosis (2 arms), sponsored by 中国中医科学院望京医院. Primary endpoint: 24-hour urine protein quantitation. Planned start Mar 2018; status: not yet recruiting.
02
Drugs
Qihuang Yishen Granule
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR1900022275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022275.